Dr. Steven Carr
Steve Carr is Director of Proteomics at the Broad Institute of MIT and Harvard. Steve and his group collaborate with scientists throughout the Broad Institute community to develop and apply state-of-the-art proteomics technology to address compelling questions in biology, chemistry, and clinical medicine. Research in his laboratory focuses on developing and applying new computational methods and mass spectrometry (MS)-based technologies to quantify proteins and their modifications and interaction partners in tissues, cells and biofluids with high sensitivity and specificity; improving informatics for peptide and protein identification by MS and integration of MS-derived data with genomic data to understand disease biology and drug effects. He is Deputy Editor of the journal Molecular and Cellular Proteomics and has >350 publications on the development and application of proteomics and biological MS. Prior to joining the Broad Institute in 2004, he held senior scientific leadership positions at GlaxoSmithKline and at Millennium Pharmaceuticals.